https://www.selleckchem.com/products/arq-197.html
There is no recommended chemotherapeutic regimen for MD adenocarcinoma. It is expected that cases should be accumulated in the future for the development of a more optimally recommended regimen. Although the incidence of our case is extremely rare, the recognition of tumor development of the embryonic remnant origin is considered important for the treatment of this adenocarcinoma. Although the incidence of our case is extremely rare, the recognition of tumor development of the embryonic remnant origin is considered important for the tre